Skip to content
10-Q

Quarterly Report

AVID BIOSERVICES, INC.

0001683168-24-006262

← back to feed
Filed
Sep 9, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Sep 3, 2024 63.8M sh
Shares Diluted Q1 2025 · Jul 31, 2024 63.64M sh
Capex Q1 2025 · Jul 31, 2024 $1.31M
Operating Cash Flow Q1 2025 · Jul 31, 2024 −$3.68M
Long Term Debt Q1 2025 · Jul 31, 2024 $53.57M
Cash And Equivalents Q1 2025 · Jul 31, 2024 $33.38M
Cash And Equivalents Q1 2025 · Apr 30, 2024 $38.11M
Stockholders Equity Q1 2025 · Jul 31, 2024 $58.64M
Stockholders Equity Q1 2025 · Apr 30, 2024 $60.89M
Current Liabilities Q1 2025 · Jul 31, 2024 $71.08M
Current Liabilities Q1 2025 · Apr 30, 2024 $70.57M
Total Liabilities Q1 2025 · Jul 31, 2024 $276.01M
Total Liabilities Q1 2025 · Apr 30, 2024 $275.67M
Current Assets Q1 2025 · Jul 31, 2024 $103.62M
Current Assets Q1 2025 · Apr 30, 2024 $104M
Total Assets Q1 2025 · Jul 31, 2024 $334.64M
Total Assets Q1 2025 · Apr 30, 2024 $336.56M
Eps Diluted Q1 2025 · Jul 31, 2024 −$0.09
Eps Basic Q1 2025 · Jul 31, 2024 −$0.09
Sga Expense Q1 2025 · Jul 31, 2024 $8.17M
Net Income Q1 2025 · Jul 31, 2024 −$5.53M
Operating Income Q1 2025 · Jul 31, 2024 −$2.46M
Gross Profit Q1 2025 · Jul 31, 2024 $5.71M
Revenue Q1 2025 · Jul 31, 2024 $40.17M